Pacific Biosciences of California, Inc. (PACB)

NASDAQ: PACB · Real-Time Price · USD

Compare

1.580

-0.130 (-7.60%)

At close: Feb 17, 2026, 4:00 PM EST

1.590

+0.010 (0.63%)

After-hours: Feb 17, 2026, 6:56 PM EST

PACB Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	279.51	55.37	179.91	325.09	460.73
Short-Term Investments	-	334.56	451.51	447.23	583.68
Cash & Short-Term Investments	279.51	389.93	631.42	772.32	1,044
Cash Growth	-28.32%	-38.25%	-18.24%	-26.05%	227.59%
Accounts Receivable	35.45	27.52	36.62	18.79	24.24
Receivables	35.45	27.52	36.62	18.79	24.24
Inventory	49.29	58.76	56.68	50.38	24.6
Prepaid Expenses	10.79	14.78	17.04	10.29	7.39
Restricted Cash	1.55	0.69	0.3	0.3	0.5
Other Current Assets	-	4	-	-	-
Total Current Assets	376.58	495.68	742.05	852.07	1,101
Property, Plant & Equipment	65.84	46.6	69.03	81.34	79.12
Goodwill	317.76	317.76	462.26	409.97	409.97
Other Intangible Assets	15.12	389.57	456.98	410.25	410.98
Other Long-Term Assets	8.77	10.84	15.7	13.45	5.76
Total Assets	784.08	1,260	1,746	1,767	2,007
Accounts Payable	20.77	16.59	15.06	12.03	11
Accrued Expenses	33.65	21.51	44.74	34.58	39.27
Current Portion of Long-Term Debt	-	-	0.49	1.84	1.61
Current Portion of Leases	-	10.03	9.59	8.89	7.71
Current Unearned Revenue	-	13.86	16.34	30.5	10.98
Other Current Liabilities	-	4.31	8.8	175.5	1.15
Total Current Liabilities	54.42	66.3	95.03	263.34	71.71
Long-Term Debt	645.38	647.49	892.24	896.68	896.07
Long-Term Leases	57.04	14.91	31.61	41.07	49.97
Long-Term Unearned Revenue	19.87	5.9	5.53	1.79	25.05
Other Long-Term Liabilities	2.03	19.25	20.3	1.3	173.19
Total Liabilities	778.73	753.85	1,045	1,204	1,216
Common Stock	5.35	0.29	0.27	0.23	0.22
Additional Paid-In Capital	-	2,655	2,540	2,100	2,010
Retained Earnings	-	-2,149	-1,839	-1,532	-1,218
Comprehensive Income & Other	-	0.42	0.22	-4.77	-1.09
Shareholders' Equity	5.35	506.59	701.3	562.9	790.99
Total Liabilities & Equity	784.08	1,260	1,746	1,767	2,007
Total Debt	702.42	672.43	933.93	948.48	955.36
Net Cash (Debt)	-422.92	-282.5	-302.51	-176.16	89.05
Net Cash Growth	-	-	-	-	-67.83%
Net Cash Per Share	-1.41	-1.03	-1.19	-0.78	0.44
Filing Date Shares Outstanding	301.91	297.85	267.95	247.08	221.18
Total Common Shares Outstanding	301.91	294.42	267.74	226.51	220.98
Working Capital	322.17	429.38	647.02	588.74	1,029
Book Value Per Share	0.02	1.72	2.62	2.49	3.58
Tangible Book Value	-327.54	-200.74	-217.94	-257.32	-29.97
Tangible Book Value Per Share	-1.08	-0.68	-0.81	-1.14	-0.14
Machinery	-	69.13	68.03	60.86	49.8
Construction In Progress	-	2.28	1.34	4.7	2.3
Leasehold Improvements	-	33.77	35.23	34.13	31.11
Order Backlog	-	31.2	18.7	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q